In-house Antibody Focus Abgent emphasizes in-house production to ensure specificity, affinity, and reproducibility, presenting a sales opportunity to offer high-quality, reproducible antibodies and related validation services to researchers who require reliable instruments for drug discovery.

High Throughput Catalog With over 1,000 new antibodies released annually and a focus on autophagy, stem cells, and neurodegeneration, there is potential to upsell expanded catalog access, sample kits, and rapid screening reagents to labs expanding into these high-demand areas.

Premium Line and Evaluations The Crown line and evaluation size vials for more than 10,000 products create an opportunity to promote premium antibodies to project teams seeking high-quality controls, as well as trial programs to convert evaluators into long-term customers.

Custom Services Advantage Abgent offers custom antibody development, peptide synthesis, and protein expression, including difficult long peptides, enabling cross-sell into bespoke research programs, collaboration opportunities, and fast turnaround services for pilot studies.

Growth Readiness As a WuXi AppTec company with mid-size scale and revenue in the tens of millions, Abgent can be positioned as a strategic supplier for mid-to-large biotech and academic accounts seeking dependable antibody platforms and integrated services within a broader ecosystem.